Noninvasive detection of salivary biomarkers, such as aMMP-8 and Lactoferrin, may provide a helpful solution to determine early disease manifestation and predict the likelihood of future periodontal breakdown, as they have been found to be increased enzymes in established advanced periodontal disease [18, 19]. This evidence concerns the gene LTF and periodontal disorder.